Literature DB >> 20397799

The abuse potential of propofol.

Courtney Wilson1, Peter Canning, E Martin Caravati.   

Abstract

CONTEXT: Propofol is a sedative-hypnotic prescription medication that is widely used in anesthesia, long-term sedation, and conscious sedation. It is short acting, effective, and, when used appropriately, safe. It is not a controlled substance by the U.S. Drug Enforcement Administration, suggesting that it has little potential for abuse. The objective of this review was to evaluate the evidence for the abuse potential of propofol.
METHODS: A systematic review of the medical literature was performed using the search terms: propofol, Diprivan, abuse, addiction, tolerance, misuse, and withdrawal. Six online literature citation databases and relevant bibliographies were searched for articles.
RESULTS: Seventy-two articles were identified for review and 45 were relevant to the topic. These articles described propofol's biochemical and pharmacokinetic mechanisms of action that lend themselves to its abuse, propofol's physical and psychological effects that make it alluring as a recreational drug, the current evidence supporting the possibility of tolerance to and withdrawal from propofol, the risk involved in recreational propofol use, and the evidence supporting current abuse of this medication. We found evidence to support propofol's abuse potential from a pharmacological and experiential standpoint with multiple reports describing tolerance, dependence, withdrawal phenomena, abuse, and death from recreational use.
CONCLUSIONS: Propofol has alluring and addictive properties that lend itself to potential recreational abuse and dependence. We recommend that the U.S. Drug Enforcement Administration and other international agencies should consider regulating propofol as a controlled substance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20397799     DOI: 10.3109/15563651003757954

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  13 in total

1.  Changes of blood endocannabinoids during anaesthesia: a special case for fatty acid amide hydrolase inhibition by propofol?

Authors:  Carina Jarzimski; Matthias Karst; Alexander A Zoerner; Christin Rakers; Marcus May; Maria T Suchy; Dimitrios Tsikas; Joachim K Krauss; Dirk Scheinichen; Jens Jordan; Stefan Engeli
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

2.  Behavioral and toxicological effects of propofol.

Authors:  Michael B Gatch; Michael J Forster
Journal:  Behav Pharmacol       Date:  2011-10       Impact factor: 2.293

3.  Propofol abuse among healthcare workers: an analysis of criminal cases using the database of the Supreme Court of South Korea's judgments.

Authors:  Hye-Yeon Cho; Yoonbin Hwang; SuHwan Shin; Susie Yoon; Ho-Jin Lee
Journal:  Korean J Anesthesiol       Date:  2022-03-15

4.  Dependence potential of propofol: behavioral pharmacology in rodents.

Authors:  Hye Jin Cha; Ji-Hun Cha; Hea-Young Cho; Eun-Yong Chung; Kyoung-Jin Kwon; Jun Yeon Lee; Ho-Sang Jeong; Hye-Soo Kim; Hye-Joo Chung; Eun Jung Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-03       Impact factor: 4.634

5.  Perspectives on the role of fospropofol in the monitored anesthesia care setting.

Authors:  Joseph V Pergolizzi; Tong J Gan; Stanford Plavin; Sumedha Labhsetwar; Robert Taylor
Journal:  Anesthesiol Res Pract       Date:  2011-04-14

6.  Sedative dosing of propofol for treatment of migraine headache in the emergency department: a case series.

Authors:  Jarrod Mosier; Grant Roper; Daniel Hays; John Guisto
Journal:  West J Emerg Med       Date:  2013-11

7.  Selective and Accurate Determination Method of Propofol in Human Plasma by Mixed-Mode Cation Exchange Cartridge and GC-MS.

Authors:  Jae Sung Pyo
Journal:  J Anal Methods Chem       Date:  2016-08-11       Impact factor: 2.193

Review 8.  Practice guidelines for propofol sedation by non-anesthesiologists: the Korean Society of Anesthesiologists Task Force recommendations on propofol sedation.

Authors:  Hyun Kang; Duk Kyung Kim; Yong-Seon Choi; Young-Chul Yoo; Hyun Sik Chung
Journal:  Korean J Anesthesiol       Date:  2016-08-18

9.  Presence of Inhibitory Glycinergic Transmission in Medium Spiny Neurons in the Nucleus Accumbens.

Authors:  Braulio Muñoz; Gonzalo E Yevenes; Benjamin Förstera; David M Lovinger; Luis G Aguayo
Journal:  Front Mol Neurosci       Date:  2018-07-11       Impact factor: 5.639

10.  Propofol abuse in professionals.

Authors:  Jaemin Lee
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.